EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
1.14.14.16 | (+)-benzphetamine + [reduced NADPH-cytochrome P-450 reductase] + O2 |
- |
Bos taurus |
N-demethyl-benzphetamine + [oxidized NADPH-cytochrome P-450 reductase] + H2O |
- |
? |
1.14.14.16 | 11,17-dihydroxyprogesterone + NADH + O2 |
- |
Bos taurus |
cortisol + NAD+ + H2O |
- |
? |
1.14.14.16 | 11beta-hydroxyprogesterone + NADH + O2 |
- |
Bos taurus |
corticosterone + NAD+ + H2O |
- |
? |
1.14.14.16 | 16,17-dehydroprogesterone + NADPH + O2 |
- |
Homo sapiens |
16,17-dehydro-21-hydroxyprogesterone + NADP+ + H2O |
- |
? |
1.14.14.16 | 17,17-dimethyl-18-norandrosta-1,4,13-trien-3-one + [reduced NADPH-hemoprotein reductase] + O2 |
i.e. metandienone |
Homo sapiens |
16beta-hydroxy-17,17-dimethyl-18-norandrosta-1,4,13-trien-3-one + 16alpha-hydroxy-17,17-dimethyl-18-norandrosta-1,4,13-trien-3-one + [oxidized NADPH-hemoprotein reductase] + H2O |
product identification by GC-EI-MS analysis |
? |
1.14.14.16 | 17,17-dimethyl-18-norandrosta-1,4,13-trien-3-one + [reduced NADPH-hemoprotein reductase] + O2 |
i.e. metandienone |
Homo sapiens |
20beta-hydroxy-17,17-dimethyl-18-norandrosta-1,4,13-trien-3-one + [oxidized NADPH-hemoprotein reductase] + H2O |
product identification by GC-EI-MS analysis |
? |
1.14.14.16 | 17-fluoro-progesterone + [reduced NADPH-P450 reductase] + O2 |
- |
Homo sapiens |
17-fluoro-11-deoxycorticosterone + [oxidized NADPH-P450 reductase] + H2O |
- |
? |
1.14.14.16 | 17-hydroxy-progesterone + NADH + O2 |
- |
Homo sapiens |
17-hydroxy-11-deoxy-corticosterone + NAD+ + H2O |
- |
? |
1.14.14.16 | 17-hydroxy-progesterone + NADH + O2 |
isozyme CYP2D |
Rattus norvegicus |
17-hydroxy-11-deoxy-corticosterone + NAD+ + H2O |
- |
? |
1.14.14.16 | 17-hydroxyprogesterone + NADPH + H+ + O2 |
- |
Homo sapiens |
11-deoxycortisol + NADP+ + H2O |
- |
? |